Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer

被引:38
作者
Gervaz, P
Cerottini, JP
Bouzourene, H
Hahnloser, D
Doan, CL
Benhattar, J
Chaubert, P
Secic, M
Gillet, M
Carethers, JM
机构
[1] CHU Vaudois, Dept Surg, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Dept Pathol, CH-1011 Lausanne, Switzerland
[3] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Ctr Canc, San Diego, CA 92103 USA
[5] Dept Vet Affairs, Res Serv, San Diego, CA USA
关键词
D O I
10.1067/msy.2002.119816
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. At least 2 apparently independent mechanisms, microsatellite instability (MSI) and chromosomal instability, are implicated in colorectal tumorigenesis. Their respective roles in predicting clinical outcomes of patients with T3N0 colorectal cancer remain unknown. Methods. Eighty-eight patients with a sporadic T3N0 colon or rectal adenocarcinoma were followed zip for a median of 67 months. For chromosomal instability analysis, Ki-ras mutations were determined by single-strand poly m erase chain reaction, and p53 protein staining was studied by immunohistochemistry. For MSI analysis, DNA was amplified by polymerase chain reaction at 7 microsatellite targets (BAT25, BAT26, D17S250, D2S123, D5S346, transforming growth factor receptor II, and BAX). Results. Overall 5-year survival rate was 72%. p53 protein nuclear staining was detected in 39 patients (44%), and MSI was detected in 21 patients (24%). MSI correlated with proximal location (P < .001) and mucinous content (P < .001). In a multivariate analysis, p53 protein expression carried a significant risk of death (relative risk = 4.0, 95% CI = 1.6 to 10.1, P = .004). By comparison, MSI was not a statistically significant prognostic factor for survival in this group (relative risk = 2.2, 95% CI = 0.6 to 7.3, P = .21). Conclusions. p53 protein overexpression provides better prognostic discrimination than MSI in predicting survival of Patients with T3N0 colorectal cancel: Although MSI is associated with specific clinico-pathologic parameters, it did not predict overall survival in this group. Assessment of p53 protein expression by immunocytochemistry provides a simple means to identify a subset of T3N0 patients with a 4-times increased risk for death.
引用
收藏
页码:190 / 197
页数:8
相关论文
共 36 条
  • [1] CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER
    AALTONEN, LA
    PELTOMAKI, P
    LEACH, FS
    SISTONEN, P
    PYLKKANEN, L
    MECKLIN, JP
    JARVINEN, H
    POWELL, SM
    JEN, J
    HAMILTON, SR
    PETERSEN, GM
    KINZLER, KW
    VOGELSTEIN, B
    DELACHAPELLE, A
    [J]. SCIENCE, 1993, 260 (5109) : 812 - 816
  • [2] PROGNOSTIC-SIGNIFICANCE OF K-RAS MUTATIONS IN COLORECTAL-CARCINOMA
    BENHATTAR, J
    LOSI, L
    CHAUBERT, P
    GIVEL, JC
    COSTA, J
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : 1044 - 1048
  • [3] Boland CR, 1998, CANCER RES, V58, P5248
  • [4] p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer
    Bouzourene, H
    Gervaz, P
    Cerottini, JP
    Benhattar, J
    Chaubert, P
    Saraga, E
    Pampallona, S
    Bosman, FT
    Givel, JC
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (08) : 1008 - 1015
  • [5] Mismatch repair proficiency and in vitro response to 5-fluorouracil
    Carethers, JM
    Chauhan, DP
    Fink, D
    Nebel, S
    Bresalier, RS
    Howell, SB
    Boland, CR
    [J]. GASTROENTEROLOGY, 1999, 117 (01) : 123 - 131
  • [6] Molecular prognostic markers and colorectal cancer: The search goes on
    Chung, DC
    [J]. GASTROENTEROLOGY, 1998, 114 (06) : 1330 - 1332
  • [7] Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer
    Curran, B
    Lenehan, K
    Mulcahy, H
    Tighe, O
    Bennett, MA
    Kay, EW
    O'Donoghue, DP
    Leader, M
    Croke, DT
    [J]. GUT, 2000, 46 (02) : 200 - 204
  • [8] Genetic and phenotypic correlates of colorectal cancer in young patients
    Datta, RV
    LaQuaglia, MP
    Paty, PB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (02) : 137 - 138
  • [9] DELATTRE O, 1989, LANCET, V2, P353
  • [10] p53 Gene mutation, microsatellite instability and adjuvant chemotherapy:: Impact on survival of 388 patients with Dukes' C colon carcinoma
    Elsaleh, H
    Powell, B
    Soontrapornchai, P
    Joseph, D
    Goria, F
    Spry, N
    Iacopetta, B
    [J]. ONCOLOGY, 2000, 58 (01) : 52 - 59